| Social entrepreneurship: Creating new business models to serve the poor C Seelos, J Mair Business horizons 48 (3), 241-246, 2005 | 2055 | 2005 |
| Profitable business models and market creation in the context of deep poverty: A strategic view C Seelos, J Mair Academy of management perspectives 21 (4), 49-63, 2007 | 1229 | 2007 |
| Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL S Kapiotis, M Hermann, I Held, C Seelos, H Ehringer, BMK Gmeiner Arteriosclerosis, Thrombosis, and Vascular Biology 17 (11), 2868-2874, 1997 | 373 | 1997 |
| The embeddedness of social entrepreneurship: Understanding variation across local communities C Seelos, J Mair, J Battilana, M Tina Dacin Communities and Organizations (Research in the Sociology of Organizations …, 2011 | 348 | 2011 |
| Scaffolding: A Process of Transforming Patterns of Inequality in Small-Scale Societies J Mair, M Wolf, C Seelos Academy of Management Journal, 2016 | 313 | 2016 |
| Social Entrepreneurship: The Contribution of Individual Entrepreneurs to Sustainable Development. IESE Business School C Seelos, J Mair Working Paper 553, 2004 | 250* | 2004 |
| Innovation and scaling for impact: How effective social enterprises do it C Seelos, J Mair Stanford university press, 2020 | 174 | 2020 |
| Innovation is not the Holy Grail C Seelos, J Mair Stanford Social Innovation Review, 2012 | 120 | 2012 |
| Entrepreneurs in service of the poor: Models for business contributions to sustainable development C Seelos, J Mair IESE Occasional Paper 04/16, 1-9, 2004 | 113 | 2004 |
| Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. C Cerni, K Bousset, C Seelos, H Burkhardt, M Henriksson, B Lüscher Oncogene 11 (3), 587-596, 1995 | 96 | 1995 |
| Social entrepreneurs directly contribute to global development goals C Seelos, K Ganly, J Mair Social entrepreneurship, 235-275, 2006 | 94 | 2006 |
| Sustainable development: How social entrepreneurs make it happen C Seelos, J Mair IESE Business School Working Paper, 2005 | 89 | 2005 |
| Sustainable development, sustainable profit C Seelos, J Mair European Business Forum 20, 49-53, 2005 | 82* | 2005 |
| Theorising and strategising with models: generative models of social enterprises C Seelos International Journal of Entrepreneurial Venturing 6 (1), 6-21, 2014 | 64 | 2014 |
| Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals M Hermann, S Kapiotis, R Hofbauer, M Exner, C Seelos, I Held, ... FEBS letters 445 (1), 212-214, 1999 | 63 | 1999 |
| The future of grand challenges research: Retiring a hopeful concept and endorsing research principles C Seelos, J Mair, C Traeger International Journal of Management Reviews, 1-19, 2022 | 62 | 2022 |
| Organizations, Social Problems, and System Change: Invigorating the Third Mandate of Organizational Research. J Mair, C Seelos Organization Theory, 2021 | 59 | 2021 |
| 12. Hope for sustainable development: how social entrepreneurs make it happen C Seelos, J Mair An Introduction to Social Entrepreneurship, 228, 2009 | 53 | 2009 |
| Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL S Kapiotis, G Sengoelge, M Hermann, I Held, C Seelos, BMK Gmeiner Arteriosclerosis, thrombosis, and vascular biology 17 (11), 2855-2860, 1997 | 49 | 1997 |
| The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein M Exner, M Hermann, R Hofbauer, S Kapiotis, W Speiser, I Held, ... FEBS letters 470 (1), 47-50, 2000 | 47 | 2000 |
